Acetonitrile → 1-((R)-3-{2-[4-(1-Cyclopropylmethyl-1H-benzoimidazol-2-yl)-[1,4]diazepan-1-yl]-ethyl}-3-phenyl-pyrrolidin-1-yl)-1-(2-methoxy-5-tetrazol-1-yl-phenyl)-methanone

HRID 2230710Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2230710
I.I.[CH:3]1([CH2:6][N:7]2[C:11]3[CH:12]=[CH:13][CH:14]=[CH:15][C:10]=3[N:9]=[C:8]2[N:16]2[CH2:22][CH2:21][CH2:20][NH:19][CH2:18][CH2:17]2)[CH2:5][CH2:4]1.[CH3:23][O:24][C:25]1[CH:30]=[CH:29][C:28]([N:31]2[CH:35]=[N:34][N:33]=[N:32]2)=[CH:27][C:26]=1[C:36]([N:38]1[CH2:42][CH2:41][C@:40]([CH2:49][CH2:50]OS(C)(=O)=O)([C:43]2[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=2)[CH2:39]1)=[O:37].C(N(CC)CC)C.C(#N)C>ClCCl>[OH-:24].[NH4+:7].[CH:3]1([CH2:6][N:7]2[C:11]3[CH:12]=[CH:13][CH:14]=[CH:15][C:10]=3[N:9]=[C:8]2[N:16]2[CH2:22][CH2:21][CH2:20][N:19]([CH2:50][CH2:49][C@:40]3([C:43]4[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=4)[CH2:41][CH2:42][N:38]([C:36]([C:26]4[CH:27]=[C:28]([N:31]5[CH:35]=[N:34][N:33]=[N:32]5)[CH:29]=[CH:30][C:25]=4[O:24][CH3:23])=[O:37])[CH2:39]3)[CH2:18][CH2:17]2)[CH2:4][CH2:5]1

Komponenten

7

Edukt 4

HCID 6342AcetonitrileHCID 8471TriethylamineHCID 184646651-cyclopropylmethyl-2-[1,4]diazepan-1-yl-1H-benzoimidazole dihydroiodideHCID 86583904HCID 86583904, Verbindung

Produkt 2

HCID 14923Ammonium HydroxideAusbeute 30 %HCID 599022641-((R)-3-{2-[4-(1-Cyclopropylmethyl-1H-benzoimidazol-2-yl)-[1,4]diazepan-1-yl]-ethyl}-3-phenyl-pyrrolidin-1-yl)-1-(2-methoxy-5-tetrazol-1-yl-phenyl)-methanoneAusbeute 130 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6344DichloromethaneLösungsmittel

Versuchsvorschrift

Reflux a mixture of 1-cyclopropylmethyl-2-[1,4]diazepan-1-yl-1H-benzoimidazole dihydroiodide (0.60 g, 1.14 mmol), methanesulfonic acid 2-{(S)-1-[1-(2-methoxy-5-tetrazol-1-yl-phenyl)-methanoyl]-3-phenyl-pyrrolidin-3-yl}-ethyl ester (0.53 g, 1.12 mmol, example 47.2), triethylamine (0.65 mL, 4.66 mmol) and acetonitrile (10 mL) for 8 hours. Cool and dilute with dichloromethane (150 mL), wash the organic phase with NaHCO3 (30 mL) and saturated brine solution (30 mL), dry (MgSO4) the organic phase, filter and evaporate. Purify the residue by silica gel chromatography (4×41 cm) eluting with dichloromethane:methanol:30% ammonium hydroxide (95:5:0.05} to afford 0.47 g of the title compound, Rf=0.32 (silica gel, dichloromethane:methanol:30% ammonium hydroxide solution. The compound may be converted to the dihydrochloride salt by methods well known in the art.

Aufarbeitung

  1. temperatureReflux
  2. temperatureCool
  3. washwash the organic phase with NaHCO3 (30 mL) and saturated brine solution (30 mL)
  4. dry with materialdry (MgSO4) the organic phase
  5. filtrationfilter
  6. customevaporate
  7. customPurify the residue by silica gel chromatography (4×41 cm)
  8. washeluting with dichloromethane

Quellen und Nachweise

ORD-Eintrag
ord-9cc1ed271fde4b80b7a45f002cc3e9f6
Quelldatensatz
uspto-grants-2002_07
Patentnummer
US06423704B1

Notizen zur Reaktion

Wird geladen…